O&G SAQs · Gynaecological health — upper genital tract infection
Pelvic inflammatory disease & tubo-ovarian abscess — structured SAQ (15 marks)
FRANZCOG-format structured SAQ on pelvic inflammatory disease: the CDC 2021 minimum criteria and threshold, the outpatient triple regimen with doses, the admission criteria, and the Westrom sequelae data. Per-sub-part marking rubric included.
On this page & tools
Target exams
How this SAQ is marked
Marks come from the verbatim CDC 2021 criteria, the exact triple regimen with doses, the admission criteria, and the Westrom sequelae numbers. Write in short labelled points. [1]
Reveal model answer and mark scheme
(a) CDC 2021 minimum criteria and threshold (3 marks)
One mark for the principle, one for the criteria, one for the threshold. [1]
- Empirically treat a sexually active at-risk woman with pelvic or lower abdominal pain, when no other cause is identified, and one or more of these minimum criteria is present:
- Cervical motion tenderness, OR uterine tenderness, OR adnexal tenderness.
- This woman meets the threshold (cervical motion and adnexal tenderness) — treat now; do not wait for NAAT results.[1]
(b) CDC 2021 outpatient regimen and counselling (4 marks)
One mark per drug (3), one for counselling. [1]
- Ceftriaxone 500 mg IM in a single dose (1 g if body weight over 150 kg), PLUS
- Doxycycline 100 mg orally twice daily for 14 days, WITH
- Metronidazole 500 mg orally twice daily for 14 days.
- Counselling (either): doxycycline — sun protection, avoid in pregnancy, take with water away from milk/antacids; OR metronidazole — covers anaerobes and is now routine (not optional) in the 2021 update.[1]
(c) CDC 2021 admission criteria — four of (4 marks)
One mark each, maximum four. [1]
Any four of:
- A surgical emergency (e.g. appendicitis) cannot be excluded.
- Tubo-ovarian abscess.
- Pregnancy.
- Severe illness, nausea and vomiting, or oral temperature over 38.5 C.
- Unable to follow or tolerate an outpatient oral regimen.
- No clinical response to oral antimicrobial therapy.[1]
(d) Long-term sequelae and Westrom data (4 marks)
One mark per sequela/number, maximum four. [2][3]
- Tubal-factor infertility: approximately 12% after one laparoscopically-verified PID episode (versus under 1% in controls).
- Risk rises steeply with the number of episodes (relative risks 1.0 / 7.0 / 16.2 / 28.3 for 0 / 1 / 2 / 3-plus), and with severity and delayed care.
- Ectopic pregnancy: the first pregnancy after PID is ectopic in about 8% (versus 1 to 2% in controls).
- Chronic pelvic pain in about a third, from adhesions and nerve injury — and subclinical PID inflicts the same damage, which is why empirical treatment on minimum criteria matters.[2][3]
You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Obstetrics & Gynaecology fellowship atlas.
References4Show ledgerHide ledger
- [1]Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep, 2021.PMID 34292926
- [2]Weström LV Sexually transmitted diseases and infertility. Sex Transm Dis, 1994.PMID 8042113
- [3]Westrom L Effect of pelvic inflammatory disease on fertility. Venereology, 1995.PMID 12291198
- [4]Marshall A, Wimsett J, Handforth C, et al. The Tubo-ovarian abscess study (TOAST): A single-center retrospective review of predictors of failed medical management. Int J Gynaecol Obstet, 2025.PMID 40162547